Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid

Supportive Care in Cancer

Volumn 17, Issue 10, 2009, Pages 1329-1330

  Polyzos, Stergios A ^a,d   Anastasilakis, Athanasios D ^b   Terpos, Evangelos ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b 424 General Army Hospital   (Greece)

^c 251 GENERAL AIR FORCE HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CALCIUM CARBONATE; PARATHYROID HORMONE; VITAMIN D; ZOLEDRONIC ACID;

ALKALINE PHOSPHATASE BLOOD LEVEL; BONE METASTASIS; BONE TURNOVER; CALCIUM BLOOD LEVEL; HUMAN; HYPERPARATHYROIDISM; HYPOCALCEMIA; LETTER; OSTEOPOROSIS; PAGET BONE DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STOMACH LYMPHOMA;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; HYPERPARATHYROIDISM; IMIDAZOLES; INFUSIONS, INTRAVENOUS; STOMACH NEOPLASMS;

EID: 70349325686     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0704-5     Document Type: Letter

References (10)

1. M Sayin G Yazici 2009 Hyperparathyroidism secondary to zoledronic acid infusion: case report Support Care Cancer 17 469 470
2. A Avramidis SA Polyzos E Moralidis 2008 Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone J Bone Miner Metab 26 635 641
3. Polyzos SA, Anastasilakis AD, Efstathiadou Z et al (2009) The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin and RANKL in patients with Paget's disease of bone. Horm Metab Res 4. doi: 10.1016/j.bone.2009.03.520
4. HE Whitson B Lobaugh KW Lyles 2006 Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone Bone 39 954 958
5. SC Cremers ME Eekhoff HJ Den NA Hamdy P Vermeij SE Papapoulos 2003 Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone J Bone Miner Res 18 868 875
6. Polyzos SA, Anastasilakis AD, Terpos E (2009) Paget's disease of bone: a review with emphasis to treatment with zoledronic acid. Expert Rev Endocrinol Metab 4 (in press)
7. B Mehrotra 2009 Bisphosphonates-role in cancer therapies J Oral Maxillofac Surg 67 19 26
8. K Nosaka T Miyamoto T Sakai H Mitsuya T Suda M Matsuoka 2002 Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells Blood 99 634 640
9. M Gavriatopoulou MA Dimopoulos D Christoulas 2009 Dickkopf-1: a suitable target for the management of myeloma bone disease Expert Opin Ther Targets 13 839 848
10. JF Seymour RF Gagel 1993 Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas Blood 82 1383 1394